Aminoguanidine: A drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro
- 5 October 1993
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 46 (7) , 1139-1144
- https://doi.org/10.1016/0006-2952(93)90461-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Effect of dietary fat on the in vitro hepatotoxicity of paracetamolBiochemical Pharmacology, 1992
- Hydrogen peroxide and ischemic renal injury: Effect of catalase inhibitionFree Radical Biology & Medicine, 1991
- Effects of aminoguanidine on pre- and post-irradiation regional cerebral blood flow, systemic blood pressure and plasma histamine levels in the primateInflammation Research, 1991
- Protein glycation and oxidative stress in diabetes mellitus and ageingFree Radical Biology & Medicine, 1991
- Hydrogen peroxide production during experimental protein glycationFEBS Letters, 1990
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988
- Extraction-spectrophotometric determination of hydrazine with 2-hydroxy-1-naphthaldehydeThe Analyst, 1987
- Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-LinkingScience, 1986
- Histamine Food Poisoning: Toxicology and Clinical AspectsCRC Critical Reviews in Toxicology, 1986
- Distribution and properties of human intestinal diamine oxidase and its relevance for the histamine catabolismBiochimica et Biophysica Acta (BBA) - General Subjects, 1983